NMN (Nicotinamide Mononucleotide) vs SS-31 (Elamipretide)
Overview
NMN (Nicotinamide Mononucleotide) is primarily a anti-aging & longevity peptide, while SS-31 (Elamipretide) is used for anti-aging & longevity.
This page compares NMN (Nicotinamide Mononucleotide) and SS-31 (Elamipretide) across their primary use, typical dosing, reported benefits and side effects, and U.S. regulatory status. For the full monograph on either compound — mechanism of action, clinical research, and references — follow the article links.
Side-by-side comparison
| NMN (Nicotinamide Mononucleotide) | SS-31 (Elamipretide) | |
|---|---|---|
| Category | Anti-aging & Longevity | Anti-aging & Longevity |
| Regulatory status (US) | Research use only | Research use only |
| Typical dosage | 250-500 mg | Clinical trials ongoing |
| Frequency | Daily oral or subQ | research |
| Reported benefits | NAD+ repletion, mitochondrial biogenesis, sirtuin activation, DNA repair. | Enhanced mitochondrial function, reduced oxidative stress, potential heart failure treatment |
| Reported side effects | Generally well-tolerated; rare GI discomfort. | Clinical trials. Side effects under study |
Key differences
Primary use. NMN (Nicotinamide Mononucleotide) is categorised under Anti-aging & Longevity, while SS-31 (Elamipretide) falls under Anti-aging & Longevity. Their differing categories mean they are usually chosen for different goals rather than as direct substitutes.
Regulatory status. NMN (Nicotinamide Mononucleotide): not FDA-approved; treated as a research compound. SS-31 (Elamipretide): not FDA-approved; treated as a research compound.
Dosing. NMN (Nicotinamide Mononucleotide) is typically dosed at 250-500 mg (Daily oral or subQ). SS-31 (Elamipretide) is typically dosed at Clinical trials ongoing (research).
Can you stack them?
Some protocols combine peptides, but stacking NMN (Nicotinamide Mononucleotide) and SS-31 (Elamipretide) has not been validated for safety or efficacy in controlled trials. Combining compounds can change their effects and risks. Nothing here is medical advice — consult a qualified healthcare provider before starting or combining any protocol.
Frequently asked questions
- What is the difference between NMN (Nicotinamide Mononucleotide) and SS-31 (Elamipretide)?
- NMN (Nicotinamide Mononucleotide) is primarily a anti-aging & longevity peptide, while SS-31 (Elamipretide) is used for anti-aging & longevity. NMN (Nicotinamide Mononucleotide) is not FDA-approved; generally classified as a research compound, whereas SS-31 (Elamipretide) is not FDA-approved; generally classified as a research compound.
- What is NMN (Nicotinamide Mononucleotide) used for?
- NAD+ direct precursor nucleotide; key longevity compound.
- What is SS-31 (Elamipretide) used for?
- Mitochondrial optimization.
- Can you take NMN (Nicotinamide Mononucleotide) and SS-31 (Elamipretide) together?
- Some users combine peptides within a single protocol, but stacking NMN (Nicotinamide Mononucleotide) and SS-31 (Elamipretide) has not been established as safe or effective in controlled trials. Neither this comparison nor PeptideSciences101 is medical advice — consult a qualified healthcare provider before combining any compounds.
- Is NMN (Nicotinamide Mononucleotide) or SS-31 (Elamipretide) FDA-approved?
- NMN (Nicotinamide Mononucleotide) is not FDA-approved; generally classified as a research compound. SS-31 (Elamipretide) is not FDA-approved; generally classified as a research compound.
Read the full articles
- NMN (Nicotinamide Mononucleotide) — full monograph: mechanism, research, dosing & references
- SS-31 (Elamipretide) — full monograph: mechanism, research, dosing & references